The North West has passed the one million mark for COVID-19 jabs administered. Nthusang Lefafa unpacks the vaccination numbers, reasons for the province having some of the lowest vaccination numbers in the country, and how it is working to catch up.
The Western Cape Department of Health has identified Khayelitsha and Mitchell’s Plain as the areas with the lowest vaccinations and vaccine registrations in the Cape Town metro. By Monday 30 August, only 22.37% of Mitchell’s Plain’s vaccine-eligible population older than 18 years have registered. In Khayelitsha, this number stood at 12.05%. Siyabonga Kamnqa visited the two areas to find out more.
Within the next month or so we will be switching gears from the comparatively small-scale trial run of Sisonke to a full-on mass vaccination programme. As with the onset of a new wave of infections, this presents a dramatic shift in the pandemic and our response to it – although in this case, the shift is finally a good thing, writes Spotlight editor Marcus Low.
Gift of the Givers founder Dr Imtiaz Sooliman has declined social media calls that he be nominated for the 2021 Nobel Peace Prize. Bienne Huisman spoke to Sooliman about the organisation’s work during the pandemic, his background, and what keeps him going.
While local experts generally welcome the order in which vaccines will be provided to different categories of people in South Africa, they are concerned that some practical nuances are unclear. Elna Schütz reports.
Before any COVID-19 vaccines can be made available in South Africa, they must be authorised by South Africa’s medicines regulator—the South African Health Products Regulatory Authority (SAHPRA). Catherine Tomlinson explores how SAHPRA is preparing to review and authorise the use of COVID-19 vaccines in the country and the different authorisation approaches they may use.
There is much talk in South Africa about a ‘second wave’ of COVID-19. In Europe, it is much more than talk, with COVID-19 diagnoses, hospital admissions, and deaths, not to mention ‘restrictions’, all on the rise. Alex Welte places in perspective what we do and do not know about herd immunity and potential second waves.